Post-IPO Market Vibes for Chinese Industrial and Humanoid Robots, with Zhiyuan and Unitree in the Spotlight
Published:
Originally published on Substack.
The robot revolution is heating up in China, and the post-IPO scene is a wild ride. Let’s break down the vibes for industrial robots and the shiny new humanoid players—Zhiyuan and Unitree—straight from the Silicon Valley of the East.
Industrial Robots: The OG Struggle
IPO Flashback: Back in 2015, names like Estun (002747.SZ), Siasun (300024.SZ), Topstar (300607.SZ), and Effert (688165.SH) went public, riding the “Made in China 2025” wave and a demand surge.
Market Reality Check: Stocks popped early thanks to policy hype, but oversupply of low-end bots, fierce competition, and tech gaps turned it into a rollercoaster. Profits? Slim to none.
Investor Takeaway: The early birds scored big with IPO exits, but retail investors are still licking their wounds from ongoing losses.
Humanoid Robots: Zhiyuan and Unitree Steal the Show
Zhiyuan Robotics (Agibot):
Big Move: In July 2025, Zhiyuan dropped $290M to grab 63.62% of Shangwei New Materials, dodging “backdoor” whispers. Deng Taihua, ex-Huawei VP, calls the shots as chairman/CEO with a $1B stake (at Zhiyuan’s $2.1B valuation), while Peng Zhihui (ex-Huawei “Genius Teen”) co-founds and leads tech as CTO.
Market Buzz: Shangwei’s stock hit seven straight 20% daily limit jumps, hitting a $530M market cap. The robot index is up 56% since September 2024, fueled by $14K price wars and a $175M China Mobile order. X is lit with speculative hype.
Investor Heads-Up: Short-term gains are popping, but R&D costs and price cuts could dim the long-term glow. Retail, watch your step.
Unitree Robotics:
Funding Frenzy: June 2025 brought a $100M Series C at a $1.7B valuation, with Tencent, China Mobile, Alibaba, and Geely jumping in. On July 18, Unitree started IPO counseling with CITIC Securities, targeting Sci-Tech STAR Market with filings due October 2025 (not September, despite X rumors).
Market Hype: Valuation soared from $1.1B in 2024 to $1.7B, with H1 and G1 robots ($14K) wowing at CES and China’s Spring Gala. X is buzzing about global potential.
Investor Note: The IPO runway looks hot, but price wars and R&D burn could cool returns. Eye that 2026 timeline and valuation risks.
The Big Picture
Industrial Robots: Stuck in a low-margin trap with import reliance, they need a tech breakthrough to win back investors.
Humanoid Bots: Zhiyuan’s Deng and Peng duo is pushing commercialization with flair (GO-1, AimRT open-source), while Unitree’s Wang Xingxing leverages quadruped-to-humanoid tech for a 1,000+ unit 2025 goal. Both face price war pitfalls, with Unitree’s IPO set for 2026, not the rumored September.
Smart Moves: Check Zhiyuan’s financials (Shangwei’s 2024: $210M revenue, $12.5M profit) and Unitree’s tech edge. Avoid the hype trap—focus on long-term profit potential and IPO progress.
Drop your thoughts below or hit me up on X—I’m all ears on this robot rollercoaster